| [1] |
GAIDAI O, CAO Y, LOGINOV S. Global Cardiovascular Diseases Death Rate Prediction[J]. Curr Probl Cardiol, 2023, 48(5): 101622. doi: 10.1016/j.cpcardiol.2023.101622 .
doi: 10.1016/j.cpcardiol.2023.101622
|
| [2] |
汪宇, 缪莹, 林强, 等. 甘油三酯葡萄糖指数联合腰围对泸州地区中老年人群10年新发冠心病的前瞻性队列研究[J]. 实用医学杂志, 2024, 40(12): 1731-1736. doi: 10.3969/j.issn. 1006-5725.2024.12.020 .
doi: 10.3969/j.issn. 1006-5725.2024.12.020
|
| [3] |
RALAPANAWA U, SIVAKANESAN R. Epidemiology and the Magnitude of Coronary Artery Disease and Acute Coronary Syndrome: A Narrative Review[J]. J Epidemiol Glob Health, 2021, 11(2): 169-177. doi: 10.2991/jegh.k.201217.001 .
doi: 10.2991/jegh.k.201217.001
|
| [4] |
ALI S, ALAM R, AHASN H, et al. Role of adipokines (omentin and visfatin) in coronary artery disease[J]. Nutr Metab Cardiovasc Dis, 2023, 33(3): 483-493. doi: 10.1016/j.numecd. 2022. 11.023 .
doi: 10.1016/j.numecd. 2022. 11.023
|
| [5] |
中华医学会, 中华医学会杂志社, 中华医学会全科医学分会, 等. 稳定性冠心病基层诊疗指南(2020年)[J]. 中华全科医师杂志, 2021, 20(3): 265-273. doi: 10.3760/cma.j.cn114798-20210120-00079 .
doi: 10.3760/cma.j.cn114798-20210120-00079
|
| [6] |
古晓东, 翁锐强, 赵俊丽, 等. NLRC3在血管内皮细胞中的功能初探及在冠心病中的诊断价值[J]. 中国病理生理杂志, 2025, 41(4): 661-668. doi: 10.3969/j.issn.1000-4718. 2025. 04.005 .
doi: 10.3969/j.issn.1000-4718. 2025. 04.005
|
| [7] |
钱程昱, 王琳升, 熊兴江, 等. 血清低密度脂蛋白胆固醇、超敏C反应蛋白联合颈动脉超声参数诊断疑似冠心病患者的价值[J]. 实用医学杂志, 2025, 41(09): 1401-1406.doi:10.3969/j.issn.1006-5725.2025.09.019 .
doi: 10.3969/j.issn.1006-5725.2025.09.019
|
| [8] |
KEDHI E, HERMANIDES R S, DAMBRINK J E, et al. TransCatheter aortic valve implantation and fractional flow reserve-guided percutaneous coronary intervention versus conventional surgical aortic valve replacement and coronary bypass grafting for treatment of patients with aortic valve stenosis and complex or multivessel coronary disease (TCW): An international, multicentre, prospective, open-label, non-inferiority, randomised controlled trial[J]. Lancet, 2025, 404(10471): 2593-2602. doi: 10.1016/S0140-6736(24)02100-7 .
doi: 10.1016/S0140-6736(24)02100-7
|
| [9] |
李明辉, 吴永健. 稳定性冠心病患者经皮冠状动脉介入治疗理念的变迁[J]. 中国循环杂志, 2025, 40(1): 95-99. doi: 10.3969/j.issn.1000-3614.2025.01.012 .
doi: 10.3969/j.issn.1000-3614.2025.01.012
|
| [10] |
TAO S, YU L, LI J, et al. Association between the triglyceride-glucose index and 1-year major adverse cardiovascular events in patients with coronary heart disease and hypertension[J]. Cardiovasc Diabetol, 2023, 22(1): 305.doi: 10.1186/s12933-023-02018-9 .
doi: 10.1186/s12933-023-02018-9
|
| [11] |
SHIMMONO H, TOKUSHIGE A, KANDA D, et al. Association of preoperative clinical frailty and clinical outcomes in elderly patients with stable coronary artery disease after percutaneous coronary intervention[J]. Heart Vessels, 2023, 38(10): 1205-1217. doi: 10.1007/s00380-023-02276-3 .
doi: 10.1007/s00380-023-02276-3
|
| [12] |
ZHAO A, XIAO H, ZHU Y, et al. Omentin-1: a newly discovered warrior against metabolic related diseases[J]. Expert Opin Ther Targets, 2022, 26(3): 275-289. doi: 10.1080/14728222. 2022.2037556 .
doi: 10.1080/14728222. 2022.2037556
|
| [13] |
GAO S, HE Y, LIU Y, et al. Dan-Lou tablets reduce inflammatory response by inhibiting the activation of NLRP3 inflammasome for coronary heart disease[J]. Phytomedicine, 2024, 131: 155773. doi: 10.1016/j.phymed.2024.155773 .
doi: 10.1016/j.phymed.2024.155773
|
| [14] |
SILALAHI T, ALWI I, SUYATNA F, et al. Curcumin's Effect on Inflammatory Response following Percutaneous Coronary Intervention in Adult Patients with Stable Coronary Heart Disease[J]. Int J Angiol, 2021, 30(2): 132-138. doi: 10.1016/j.phymed. 2024.155773 .
doi: 10.1016/j.phymed. 2024.155773
|
| [15] |
KARAMPELA I, VALLIANOU N G, TSILINGIRIS D, et al. Diagnostic and Prognostic Value of Serum Omentin-1 in Sepsis: A Prospective Study in Critically Ill Patients[J]. Medicina (Kaunas), 2023, 59(5): 833. doi: 10.3390/medicina59050833 .
doi: 10.3390/medicina59050833
|
| [16] |
YIN L, TANG H, QU J, et al. Chemerin regulates glucose and lipid metabolism by changing mitochondrial structure and function associated with androgen/androgen receptor[J]. Am J Physiol Endocrinol Metab, 2024, 326(6): E869-E887. doi: 10.1152/ajpendo.00104.2023 .
doi: 10.1152/ajpendo.00104.2023
|
| [17] |
WANG Y, ZHANG X, REN M, et al. LncRNA LUCAT1 offers protection against human coronary artery endothelial cellular oxidative stress injury through modulating hsa-miR-6776-5p/LRRC25 axis and activating autophagy flux[J]. J Transl Med, 2024, 22(1): 1171. doi: 10.1186/s12967-024-05966-2 .
doi: 10.1186/s12967-024-05966-2
|
| [18] |
WANG Y, LIU Y, YANG R, et al. Remnant cholesterol for the detection of glucose metabolic states in patients with coronary heart disease angina pectoris[J]. Acta Diabetol, 2022, 59(10): 1339-1347. doi: 10.1007/s00592-022-01935-7 .
doi: 10.1007/s00592-022-01935-7
|
| [19] |
KO C Y, LIN Y Y, ACHUDHAN D, et al. Omentin-1 ameliorates the progress of osteoarthritis by promoting IL-4-dependent anti-inflammatory responses and M2 macrophage polarization[J]. Int J Biol Sci, 2023, 19(16): 5275-5289. doi: 10.7150/ijbs. 86701 .
doi: 10.7150/ijbs. 86701
|
| [20] |
MA L, ZHANG X, ZHANG C, et al. Omentin-1 attenuates inflammation and barrier damage in DSS-induced ulcerative colitis in mice by inhibiting endoplasmic reticulum stress[J]. Gen Physiol Biophys, 2022, 41(3): 221-230. doi: 10.4149/gpb_2022012 .
doi: 10.4149/gpb_2022012
|
| [21] |
HUANG X, CHEN C, CHEN Y, et al. Omentin-1 alleviate interleukin-1β(IL-1β)-induced nucleus pulposus cells senescence[J]. Bioengineered, 2022, 13(5): 13849-13859. doi: 10.1080/21655979.2022.2084495 .
doi: 10.1080/21655979.2022.2084495
|
| [22] |
WU Q, CHEN Y, CHEN S, et al. Correlation between adiponectin, chemerin, vascular endothelial growth factor and epicardial fat volume in patients with coronary artery disease[J]. Exp Ther Med, 2020, 19(2): 1095-1102. doi: 10.3892/etm.2019.8299 .
doi: 10.3892/etm.2019.8299
|
| [23] |
TANG C, CHEN G, WU F, et al. Endothelial CCRL2 induced by disturbed flow promotes atherosclerosis via chemerin-dependent β2 integrin activation in monocytes[J]. Cardiovasc Res, 2023, 119(9): 1811-1824. doi: 10.1093/cvr/cvad085 .
doi: 10.1093/cvr/cvad085
|
| [24] |
乔羽, 王晓磊, 吴长江, 等. 葛根-丹参对糖尿病相关动脉粥样硬化小鼠脂肪因子稳态的影响[J]. 中国病理生理杂志, 2024, 40(12): 2238-2244. doi: 10.3969/j.issn.1000-4718. 2024.12.006 .
doi: 10.3969/j.issn.1000-4718. 2024.12.006
|
| [25] |
KUKLA M, MENZYK T, DEMBINSKI M, et al. Anti-inflam-matory adipokines: Chemerin, vaspin, omentin concentrations and SARS-CoV-2 outcomes[J]. Sci Rep, 2021, 11(1): 21514. doi: 10.1038/s41598-021-00928-w .
doi: 10.1038/s41598-021-00928-w
|
| [26] |
SU X, CHENG Y, ZHANG G, et al. Chemerin in inflammatory diseases[J]. Clin Chim Acta, 2021, 517: 41-47. doi: 10.1016/j.cca.2021.02.010 .
doi: 10.1016/j.cca.2021.02.010
|